BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34258957)

  • 21. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
    Ju W; Luo X; Zhang N
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
    You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
    Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
    Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
    Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].
    Weng X; Li JS; Fan S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Oct; 38(5):550-557. PubMed ID: 33085241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and functions of long non-coding RNA actin filament-associated protein 1-antisense RNA1 in oral squamous cell carcinoma].
    Geng YD; Wang SB; Lu TQ; Teng W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Dec; 37(6):594-601. PubMed ID: 31875436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
    Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
    Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer.
    Liu L; Zhan Y; Huang Y; Huang L
    J Oral Pathol Med; 2020 Mar; 49(3):243-252. PubMed ID: 31899825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Knockdown of long non-coding RNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) inhibits epithelial-mesenchymal transition, invasion and migration of TPC-1 papillary thyroid cancer cells].
    Fan H; Dong Q; Yu J; Yin L; Sun X; Yang X; Zhang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):54-60. PubMed ID: 33441229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of lncRNA snaR is correlated with postoperative distant recurrence of HPV-negative cervical squamous cell carcinoma.
    Zheng Z; Gao Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30249756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
    Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
    Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.
    Shen H; Sun B; Yang Y; Cai X; Bi L; Deng L; Zhang L
    Odontology; 2020 Oct; 108(4):553-559. PubMed ID: 32016787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
    Qiao B; Johnson NW; Gao J
    Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
    Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
    Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ENAH-202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502/VIM axis.
    Zhang X; Chen X; Sun D; Song N; Li M; Zheng W; Yu Y; Ding G; Jiang Y
    Cancer Med; 2023 Nov; 12(22):20892-20905. PubMed ID: 37902191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
    Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
    J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.